BriaCell Therapeutics Corp. (NASDAQ:BCTX)’s share price traded up 11.3% during mid-day trading on Monday . The stock traded as high as $4.35 and last traded at $4.23. 1,918,093 shares changed hands during trading, an increase of 284% from the average session volume of 499,356 shares. The stock had previously closed at $3.80.
BriaCell Therapeutics Company Profile (NASDAQ:BCTX)
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test.
Further Reading: Dead Cat Bounce
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.